In 2025, children diagnosed with cancer face a reality measured in thousands and outcomes that do not look the same for every family. Even small differences in stage at diagnosis, treatment access, and age can shift survival chances in surprising ways. Let’s break down the Kids Cancer statistics to see what is changing and what still needs attention.
Key Takeaways
- In the United States, approximately 15,780 children and adolescents ages 0-19 were diagnosed with cancer in 2024
- Global annual funding for childhood cancer research is $150 million
- Genetic syndromes like Down syndrome increase leukemia risk 10-20 fold in children
- The 5-year survival rate for all childhood cancers combined in the US (diagnosed 2014-2020) is 86.4%
- Chemotherapy is used in 60-70% of childhood cancer treatments
Early detection and better treatments help thousands of children with cancer survive and thrive.
Related reading
01 · Category
Incidence and Prevalence30 stats
01
In the United States, approximately 15,780 children and adolescents ages 0-19 were diagnosed with cancer in 2024
02
Globally, childhood cancer incidence is estimated at 397,000 new cases per year among children aged 0-19
03
Leukemia accounts for about 28% of all childhood cancers in the US, making it the most common type
04
Brain and other central nervous system tumors represent 26% of childhood cancers in children under 15 in the US
05
In Europe, the annual incidence rate of childhood cancer is about 35 per million children aged 0-14
06
In low- and middle-income countries, 90% of childhood cancer cases occur, but only 20% have access to treatment
07
The incidence rate of childhood cancer in the UK is 147 per million children aged 0-14
08
Neuroblastoma incidence is about 10.2 cases per million children under 15 in the US
09
Wilms tumor (kidney cancer) affects about 500 children annually in the US
10
Retinoblastoma incidence is 11.8 per million children under 5 worldwide
11
Hodgkin lymphoma in children aged 0-19 has an incidence of 1.9 per 100,000 in the US
12
Non-Hodgkin lymphoma incidence in US children 0-19 is 1.4 per 100,000
13
In Australia, childhood cancer incidence is 16.3 per 100,000 children under 15
14
Rhabdomyosarcoma incidence is 4.5 per million children aged 0-19 in the US
15
Germ cell tumors in children have an incidence of 3.4 per million under 20 in the US
16
In India, childhood cancer incidence is estimated at 41,000 new cases per year
17
Thyroid cancer in adolescents aged 15-19 has incidence of 6.5 per 100,000 in the US
18
Bone cancers like osteosarcoma incidence is 5.0 per million children under 20 in the US
19
In Canada, 1,050 children under 15 are diagnosed with cancer each year
20
Ewing sarcoma incidence is 2.9 per million children and adolescents in the US
21
Liver cancer in children under 20 has incidence of 1.8 per million in the US
22
In Brazil, childhood cancer incidence rate is 139 per million children 0-14
23
Melanoma incidence in children 0-19 is 0.3 per 100,000 in the US
24
In South Africa, childhood cancer incidence is around 100-150 per million under 15
25
Soft tissue sarcomas excluding rhabdomyosarcoma: 2.5 per million children in US
26
In Japan, childhood leukemia incidence is 4.4 per 100,000 under 15
27
Colorectal cancer in children 0-19: 0.2 per 100,000 in US
28
In Nigeria, estimated 1,276 new childhood cancer cases in 2020
29
Adrenocortical carcinoma in children: 0.2 per million under 20 in US
30
Overall childhood cancer incidence in US 0-19: 17.9 per 100,000
Interpretation
Incidence and Prevalence Interpretation
The brutal arithmetic of childhood cancer reveals a global crisis where the disease is most common in places least equipped to fight it, turning a statistic like '90% of cases but only 20% with treatment' into an unforgvable sentence for our world.
02 · Category
Research, Funding, and Awareness29 stats
01
Global annual funding for childhood cancer research is $150 million
02
St. Jude Children's Research Hospital treats 8,600 kids annually, no family pays
03
Worldwide Childhood Cancer Initiative aims to achieve 60% survival globally by 2030
04
US NCI allocates $300 million yearly to pediatric cancer research
05
Alex's Lemonade Stand Foundation raised $300 million since 2005 for research
06
CureSearch for Children's Cancer funds 50+ clinical trials annually
07
400+ pediatric cancer clinical trials active in US per year
08
International Childhood Cancer Day (Feb 15) raises awareness globally since 2002
09
EU funded 100+ pediatric oncology projects with €500 million in Horizon 2020
10
Pediatric MATCH trial screened 1,000+ kids for targeted therapies
11
Stand Up To Cancer raised $750 million total, including pediatric grants
12
Childhood Cancer Awareness Month (September) boosts donations 30%
13
1,400+ scientists at St. Jude work on childhood cancer
14
WHO's Global Childhood Cancer Initiative launched in 2018 with 50 countries
15
NCI Pediatric Central Institutional Review Board reviews 500+ trials yearly
16
Hyundai Hope on Wheels granted $230 million since 1998 for research
17
ACCELERATE platform harmonizes 30+ global pediatric trials
18
50% of new pediatric cancer drugs approved via accelerated FDA pathways
19
Children's Oncology Group (COG) enrolls 8,000 kids in trials yearly
20
Target Cancer Foundation supports 100+ rare pediatric tumor studies
21
Annual World Congress on Pediatric Oncology draws 2,000 experts
22
$1.2 billion US federal funding for pediatric cancer in FY2023 via Cures Act
23
Rally Foundation grants $20 million+ to 200+ research projects
24
SIOP PODC network improves care in 100+ LMICs
25
20,000+ childhood cancer survivors tracked in CCSS long-term study
26
Moon Shot for Kids invested $50 million in immunotherapy research
27
EUSA Pharma funds 10+ trials for pediatric sarcoma therapies
28
75% of childhood cancers now have targeted therapy trials
29
Gold Ribbon Hero Campaign raises $5 million yearly for neuroblastoma
Interpretation
Research, Funding, and Awareness Interpretation
We have pieced together an impressive, collaborative mosaic of funding, research, and care for childhood cancer, but each dazzling tile is still a stark reminder of the monumental and underfunded battlefield we're trying to conquer.
03 · Category
Risk Factors and Causes25 stats
01
Genetic syndromes like Down syndrome increase leukemia risk 10-20 fold in children
02
Ionizing radiation exposure before age 15 increases leukemia risk by 2-3 times
03
Parental smoking associated with 8-10% increased risk of childhood leukemia
04
In utero exposure to pesticides increases childhood leukemia risk by 40-60%
05
Li-Fraumeni syndrome confers 50% lifetime cancer risk, mostly in childhood
06
Beckwith-Wiedemann syndrome increases Wilms tumor risk 7-10%
07
HIV infection raises risk of childhood cancers like NHL and Kaposi sarcoma
08
EBV infection linked to 50% of endemic Burkitt lymphoma in children
09
High birth weight (>4kg) associated with 50% increased leukemia risk
10
Fanconi anemia increases leukemia risk 700-1000 fold
11
Maternal alcohol consumption during pregnancy raises neuroblastoma risk by 50%
12
Electromagnetic fields (EMF) exposure may increase childhood leukemia risk by 1.4-2 times
13
Ataxia-telangiectasia syndrome: 40% develop cancer by age 20, mostly leukemia/lymphoma
14
Congenital anomalies increase childhood cancer risk 2.4 fold overall
15
Benzene exposure from traffic increases leukemia risk 20-40% in children
16
Neurofibromatosis type 1: 8-13% lifetime risk of optic glioma in children
17
Oligohydramnios during pregnancy linked to higher Wilms tumor risk
18
Immunosuppression post-transplant raises lymphoma risk 100-fold in kids
19
Familial adenomatous polyposis increases hepatoblastoma risk 100-800 fold
20
No strong link between vaccines and childhood leukemia, risk increase <1%
21
Over 5% of childhood cancers linked to known genetic predisposition syndromes
22
Secondhand smoke increases neuroblastoma risk by 24%
23
Male sex slightly increases risk for most childhood cancers (incidence 10-20% higher)
24
Advanced parental age (>40) raises risk of childhood brain tumors by 50%
25
95% of childhood cancers have no known preventable cause
Interpretation
Risk Factors and Causes Interpretation
While we can identify many alarming triggers, from genetic landmines to environmental trespasses, the sobering truth is that for most childhood cancers we are still searching for the map in the dark.
More related reading
04 · Category
Survival and Mortality Rates26 stats
01
The 5-year survival rate for all childhood cancers combined in the US (diagnosed 2014-2020) is 86.4%
02
Childhood acute lymphoblastic leukemia (ALL) 5-year survival is 91.7% in the US (2014-2020)
03
Brain and CNS cancer 5-year survival in children under 15 is 75.2% in high-income countries
04
US neuroblastoma 5-year survival is 80.6% overall (2014-2020)
05
Wilms tumor 5-year survival exceeds 90% with treatment in the US
06
Hodgkin lymphoma in children: 98.9% 5-year survival in US (2014-2020)
07
Non-Hodgkin lymphoma childhood 5-year survival: 87.9% in US
08
Rhabdomyosarcoma 5-year survival: 64.6% in US children (2014-2020)
09
Osteosarcoma 5-year survival: 68.4% in adolescents under 20 US
10
Ewing sarcoma 5-year survival: 70.8% in US youth
11
Retinoblastoma 5-year survival: over 95% in developed countries
12
In UK, childhood cancer 5-year survival improved to 84% for 2016-2020 diagnoses
13
Global childhood cancer mortality: 96,000 deaths per year in 0-14 age group
14
US childhood cancer mortality rate declined 69% from 1970-2021
15
Acute myeloid leukemia (AML) in children: 66.8% 5-year survival US
16
Medulloblastoma 5-year survival: 72% in children
17
In LMICs, only 30% of children with cancer survive 5 years vs 80% in HICs
18
US hepatoblastoma 5-year survival: 71.8%
19
Thyroid cancer in youth: 99.8% 5-year survival US
20
Soft tissue sarcoma 5-year survival excluding rhabdo: 73.2% US children
21
In Australia, childhood ALL survival 94% at 5 years
22
Germ cell tumors 5-year survival: 88.6% in US children
23
Melanoma in children: 96.5% 5-year survival US
24
Adrenocortical carcinoma childhood survival: 52.5% at 5 years US
25
Overall US childhood cancer mortality: 2.3 per 100,000 in 0-19
26
In Europe, 5-year survival for childhood cancer 81% (2010-2014)
Interpretation
Survival and Mortality Rates Interpretation
These statistics reveal a battlefield of remarkable progress, where hope now typically wins, but it's a victory still tragically denied to many and fiercely contested in every corner.
05 · Category
Treatment and Therapies24 stats
01
Chemotherapy is used in 60-70% of childhood cancer treatments
02
CAR-T cell therapy achieves 80-90% remission in relapsed B-ALL children
03
Proton beam therapy reduces long-term side effects by 50% vs traditional radiation in brain tumors
04
Imatinib (Gleevec) achieves 90% event-free survival in Ph+ ALL kids
05
Surgery is primary treatment for 20% of localized Wilms tumors
06
High-dose chemotherapy with stem cell transplant cures 50-60% relapsed neuroblastoma
07
Rituximab improves survival by 20% in pediatric B-cell NHL
08
Cochlear implants help 80% of children with hearing loss from chemo/radiation
09
Bispecific antibodies like blinatumomab: 44% complete remission in relapsed ALL
10
Total body irradiation avoided in 70% of pediatric transplants with new regimens
11
Dinutuximab beta extends survival by 20% in high-risk neuroblastoma
12
Multidisciplinary care teams improve outcomes by 15-20% in childhood cancer
13
Larotrectinib achieves 75% response rate in NTRK fusion pediatric solid tumors
14
Neoadjuvant chemotherapy shrinks 80% of osteosarcoma tumors before surgery
15
Venetoclax combined with chemo: 90% response in relapsed AML kids
16
Growth hormone therapy safe post-treatment for 95% of survivors
17
GD2-targeted vaccine boosts survival 10-15% in neuroblastoma
18
Ifosfamide/etoposide regimen: 70% response in relapsed rhabdomyosarcoma
19
Intra-arterial chemotherapy preserves eyes in 90% unilateral retinoblastoma
20
TKIs like crizotinib: 65% response in ALK+ anaplastic large cell lymphoma
21
Supportive care reduces infection mortality from 20% to 2% in neutropenic kids
22
3D-printed prosthetics customized for 100% of amputee pediatric patients
23
Haploidentical transplants successful in 85% of pediatric leukemia cases now
24
Anti-PD1 immunotherapy: 30-40% response in relapsed Hodgkin lymphoma kids
Interpretation
Treatment and Therapies Interpretation
Amid the sobering landscape of pediatric oncology, a brilliant mosaic of innovation is emerging, where targeted therapies are rewriting survival scripts, meticulous care is softening collateral damage, and relentless science is steadily converting daunting statistics into stories of reclaimed childhood.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
James Okoro. (2026, February 13). Kids Cancer Statistics. Gitnux. https://gitnux.org/kids-cancer-statistics
MLA
James Okoro. "Kids Cancer Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/kids-cancer-statistics.
Chicago
James Okoro. 2026. "Kids Cancer Statistics." Gitnux. https://gitnux.org/kids-cancer-statistics.
Sources & references
42 datasets cited across this report · attribution is report-level